You are now leaving novonordisk-hrt.co.uk
You are about to leave the website of novonordisk-hrt.co.uk and view the content of an external website.
Novo Nordisk UK cannot be held responsible for the content of external websites.
You are now leaving novonordisk-hrt.co.uk
You are about to leave the website of novonordisk-hrt.co.uk and go to novonordisk.co.uk
Do you wish to continue?
Novo Nordiskalternative HRTs
The prescribing decision should be based on your professional judgement and the individual needs of your patient.
Continuous combined oral HRT preparation
containing 1 mg of oestradiol
Kliovance®
1mg oestradiol + 0.5mg norethisterone acetate
Continuous combined oral HRT preparation
containing 2 mg of oestradiol
Kliofem®
2mg oestradiol + 1mg norethisterone acetate
Combined sequential oral HRT preparation
containing 1 mg of oestradiol
Novofem®
1 mg oestradiol + 1 mg norethisterone acetate
Combined sequential oral HRT preparation
containing 2 mg of oestradiol
Trisequens®
2mg/2mg/1mg oestradiol + 1mg norethisterone acetate
References:
1. British Menopause Society. HRT preparations and equivalent alternatives https://thebms.org.uk/wp-content/uploads/2019/11/HRT-alternatives-04.11.2019.pdf (Accessed 25 June 2020). 2. Kliovance® Summary of Product Characteristics. 3. Kliofem® Summary of Product Characteristics. 4. Novofem® Summary of Product Characteristics. 5. Trisequens® Summary of Product Characteristics.
This is a Novo Nordisk® website intended for UK healthcare professionals
Date of preparation: July 2020 UK20VG00009 Privacy Policy Contact us
This is a Novo Nordisk® website intended for healthcare professionals
Date of preparation: July 2020
UK20VG00009
Privacy Policy Contact us
